Methylphenidate dosage

Previous Methylphenidate Dosage Recommended Ritalin LA Dosage... 

Sebrechts, M.M., Shaywitz, S.E., Shaywitz, B.A., Jatlow, P., Anderson, G.M., and Cohen, D.J. (1986) Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. Pediatr 77 222—228. 

Kupietz, S.S., Winsberg, B.G., Richardson, E., Maitinsky, S., and Mendell, N. (1988) Effects of methylphenidate dosage in hyperactive reading-disabled children I. Behavior and cognitive performance effects. J Am Acad Child Adolesc Psychiatry 27 70-77. 

A 5-year-old hyperkinetic epileptic boy taking phenytoin 8.9 mg/kg and primidone 17.7 mg/kg daily, developed ataxia without nystagmus when he was also given methylphenidate 40 mg daily. Serum levels of both the anti epileptics were found to be at toxic levels and only began to fall when the methylphenidate dosage was reduced. ... 

Dopaminergic mechanisms within the ventral striatum (i.e., nucleus accumbens) subserve the ability of amphetamine and methylphenidate in low to moderate doses to increase locomotor activity. In contrast, very low dosages in animals seem to cause hypoactivity presumably by stimulation of autoreceptors, a finding that would be compatible with the clinical impression that methylphenidate might be usefiil in some patients with mania. 

Amphetamines are synthetic sympthetomimetic amines that are powerful CNS stimulators, of few of which, in particular dextroamphetamine (8.1.2.2) and methylphenidate (8.1.2.6), are sometimes used for treating depressive conditions. They elevate mood, stimulate motor activity, vigilance, and allow one to concentrate better. However, depending on the dosage and personality of the patient, it may cause various degrees of euphoria, which frequently leads to dependence and addiction. 

Drug dependence Give methylphenidate cautiously to emotionally unstable patients, such as those with a history of drug dependence or alcoholism, because such patients may increase dosage on their own initiative. 

Patients new to methylphenidate - The recommended starting dose for patients who are not currently taking methylphenidate or for patients who are on stimulants other than methylphenidate is 18 mg once/day. Dosage may be adjusted in 18 mg increments at weekly intervals to a maximum of 54 mg/day taken once/day in the morning for children 6 to 12 years of age, and a maximum of 72 mg/day (not to exceed 2 mg/kg/day) for adolescents 13 to 17 years of age. 

Previous methylphenidate daily dosage Recommended Concerta starting dose... 

Patients currently using methylphenidate - The recommended dosage of Ritalin LA for patients currently taking methylphenidate twice daily or SR is provided in the following table. For other methylphenidate regimens, use... 

Methylphenidate as a secondary amine gives rise to four optical isomers d-threo, 1-threo, d-erythro, and 1-erythro. There is stereoselectivity in receptor site binding and its relationship to response. The standard preparation is comprised of the threo recemate as it appears to be the CNS active form. Moreover, recent data suggests that the d-methylphenidate isomer is the active form. This has led to the development of a purified d, threo-methylphenidate compound, Focalin. Studies have shown Focalin to be at least as effective as the racemate at half the dosage. Focalin is available in 2.5, 5, and 10 mg to approximate 5, 10, and 20 mg of d,l methylphenidate. 

Douglas, V., Barr, R., Amin, K., O Neill, M., Britton, B. (1988) Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. / Child Psychol Psychiatry 29 453-475. 

Biederman J, Quinn D, Weiss M, et al Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs 5 833-841, 2003... 

Clonidine hydrochloride (Catapres), carbamazepine (Tegretol), and methylphenidate (Ritalin) are occasionally useful in intractable cases of migraine. Cyproheptadine (Periactin) may be effective in adults with migraine it is of considerable importance in the treatment of childhood migraine, and many consider it to be the drug of first choice. Dosages range from 4 to 3 mg, three to four times a day, in adults and 4 mg, two to three times a day, in children. 

Withdrawal from methylphenidate abuse can be both difficult and dangerous. Medical reference books warn that MPH withdrawal should be undertaken with careful supervision by slowly reducing dosages over time. 

A search of the available literature failed to produce evidence that methylphenidate has been used by the military to counteract fatigue in operational environments. However, the U.S. Navy has conducted laboratory studies in which military personnel were administered 10 mg methylphenidate or 37.5 mg pemoline during 64 hr of continuous wakefulness. The results indicated that methylphenidate did not produce improvements in objective and subjective sleepiness, or in straightforward measures of performance (27,46). However, when the performance data from a choice-reaction-time test were analyzed for trial-to-trial variance, methylphenidate was found to decrease the variance compared to placebo on the first of 2 days of sleep deprivation. The effect did not continue into the second day (51). As was the case with the vigilance studies (above), the nonsignificant or relatively small effects of methylphenidate may have resulted from the low dosage that was studied. 

In other studies, methylphenidate has been shown to improve subjective mood evaluations in both adults (44) and children (42). A comparison between d-amphetamine, /-amphetamine, and methylphenidate (administered in dosages equimolar to 10 mg or 20 mg) indicated that methylphenidate s euphoric effects were between those found with rf-amphetamine and /-amphetamine (55). In the earlier-mentioned study by Coons et al. (49), methylphenidate increased subjective ratings of concentration and aggression compared to placebo. In the study by Peloquin and Klorman (42), 0.3 mg/kg methylphenidate prevented the increased ratings of dysphoria over time, and produced an overall lower dysphoria rating than placebo. In Roehrs et al. (53), methylphenidate (10 mg) remedied the adverse... 

From January 1996 to December 1997, about 700,000 dosage units of methylphenidate were reported to the drug theft database. 

A 22-year-old man who had had ADHD since the age of 8 years took methylphenidate, and had an adequate response for 14 years (52). However, his symptoms worsened and he switched from methylphenidate to mixed amfetamine salts 20 mg bd. A month later he continued to have difficulty in focusing on tasks, and the dosage was eventually increased to 45 mg tds over several weeks, with symptomatic improvement. However, 5 days later, he awoke feeling nauseated and agitated and had choreiform movements of his face, trunk, and limbs. He had also taken escitalopram 10 mg/day for anxiety and depression for 2 months before any changes in his ADHD medications. He was treated with intravenous diphenhydramine, lora-zepam, and diazepam without improvement in the chorea. Amfetamine was withdrawn and 3 days later his chorea abated. He restarted methylphenidate and the movement disorders did not recur. 

Concerta, Metadate Continuous Dosage (CD), Metadate Extended Release (ER), Methylin, Methylin Sustained Release (SR), Ritalin, Ritalin Long-Acting (LA), Ritalin-SR PMS-Methylphenidate... 

A 10-year-old boy, who had received a heart transplant 6 years previously, started taking methylphenidate 5 mg twice daily in addition to his transplant medication, which included ciclosporin. Aifter4 days his ciclosporin level was found to have risen from 195 to 302 nanograms/mL. His ciclosporin dosage was therefore reduced from 550 to 500 mg daily, and at the same time the methylphenidate was increased to 7.5 mg twice daily. As the next ciclosporin level was still elevated at 251 nanograms/mL, the ciclosporin dose was further reduced to 450 mg daily. The boy then remained on this dose of ciclosporin with acceptable levels, despite further dose increases in the methylphenidate to an eventual dose of 20 mg daily. ... 

A 14-year-old boy taking methylphenidate 60 mg daily was additionally given bupropion 200 mg increased to 300 mg daily. The patient experienced grand mal seizures 4 weeks after the dosage increase, but remained seizure-free onee the bupropion was discontinued. Another report describes aeute myoeardial infarction in a 16-year-old boy associated with methylphenidate, bupropion and erythromycin. It was proposed that the erythromyein might have eaused elevated levels of bupropion leading to a... 

A case report describes a patient treated with trazodone, isocarboxazid and methylphenidate who developed symptoms of the serotonin syndrome. The US manufaeturer says due to the absence of clinical experience, if MAOIs are diseontinued shortly before or are to be given concurrently with trazodone, therapy should be initiated cautiously with a gradual increase in dosage until optimum response is achieved. However, the UK manufaeturer of trazodone says possible interactions with MAOIs have occasionally been reported they do not recommend concurrent use, nor should trazodone be given within 2 weeks of stopping an MAOI. MAOIs should not be taken within one week of stopping trazodone. ... 

An 11-year-old boy with ADHD was given methylphenidate and after the daily dosage had been titrated to 20 mg enuresis started to occur. After 2 months, the medication was withdrawn and the enuresis stopped immediately. About 1 month later, methylphenidate was restarted and the enuresis reoccurred when the dose reached 20 mg/day. It continued for about 3 months but immediately stopped when the medication was withdrawn. Another rechallenge after 2 months, followed by withdrawal of methylphenidate, replicated the response. Other causes of enuresis were excluded and the patient never had daytime urinary incontinence. 

---